Product Information
CARBAMAZEPINE ER 100 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2239 per EA under NDC 62135092760. Its NADAC has been published 57 times since May 28, 2025.
Strength
100 mg/1
Manufacturer
Chartwell RX LLCNDC
62135092760
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215591On Market Since
3/31/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE ER 100 MG TABLET has been published 57 times since May 28, 2025, and over the history we have for it it has declined 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2239 per EA |
|---|---|
| All-time high | $0.2610 (Nov 12, 2025) |
| All-time low | $0.2239 (Jun 17, 2026) |
| 52-week high | $0.2610 |
| 52-week low | $0.2239 |
| Median price | $0.2474 |
| Average price | $0.2456 |
| Largest weekly change | -7.8% (Jan 21, 2026) |
| Weeks tracked | 57 |
| Tracking since | May 28, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Carbamazepine ER market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE ER 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 100 MG TABLET, manufactured by Chartwell RX LLC, is $0.2239 per EA (NDC 62135092760), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE ER 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE ER 100 MG TABLET has declined 9.5%. It has been tracked across 57 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 100 MG TABLET?
Since May 28, 2025, the NADAC for CARBAMAZEPINE ER 100 MG TABLET has ranged from a low of $0.2239 (Jun 17, 2026) to a high of $0.2610 (Nov 12, 2025), with a median of $0.2474 per EA.
Are there cheaper alternatives to CARBAMAZEPINE ER 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBAMAZEPINE ER 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CARBAMAZEPINE ER 100 MG TABLET?
CARBAMAZEPINE ER 100 MG TABLET (NDC 62135092760) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification